Search

Search Constraints

You searched for: Author/Creator Gottenberg, Jacques-Eric

Search Results

31. Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection. (15th December 2017)

32. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations. (1st February 2016)

33. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Issue 3 (March 2021)

34. Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial. Issue 3 (9th November 2020)

35. Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome. Issue 2 (28th October 2019)

36. Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Issue 6 (21st December 2012)

37. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Issue 8 (13th April 2012)

38. Epidemiological profile and north–south gradient driving baseline systemic involvement of primary Sjögren's syndrome. (24th December 2019)

39. Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort. Issue 1 (20th April 2016)

40. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Issue 1 (23rd April 2020)